Course Overview

Physiological Effects and Clinical Impact of Nasal High Flow Therapy in Infants and Young Children 2022 - Certificate

CertificateInteractiveAllergy/Immunology, *Asthma & Allergy, *Respiratory, *Allied Health Professional, *Free Respiratory Courses , *Partners SolutionsX2, **Self-Study/On-Demand
  • Course Credit Type:Certificate
  • Course Category:Allergy/Immunology, *Asthma & Allergy, *Respiratory, *Allied Health Professional, *Free Respiratory Courses , *Partners SolutionsX2, **Self-Study/On-Demand
  • Course Format:Interactive
  • Course Credit:1.00
  • Course Cost:Free
  • Accreditation:This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063
  • Faculty:Donna Franklin, PhD, Andreas Schibler, M.D
  • Course Release Date:February 14, 2022
  • Course Expiration Date:February 14, 2023
  • Mobile Friendly:Yes
  • Course Producer:Solutions X2
  • Rewards Points Earned:25
course image
You need to  log in  or  create a user account  before you can enroll.

Program Summary

A one-hour presentation and moderated discussion of the physiological outcomes and clinical impact of nasal high flow therapy; focusing on the results and implications of the PARIS trial in young infants with bronchiolitis. For FPH hosted group viewing sessions, please use the attached csv file to take attendance and email your completed roster to solutionsx2@comcast.net EIA Sign In Sheet Template

A one-hour presentation and moderated discussion of the physiological outcomes and clinical impact of nasal high flow therapy; focusing on the results and implications of the PARIS trial in young infants with bronchiolitis.



For FPH hosted group viewing sessions, please use the attached csv file to take attendance and email your completed roster to solutionsx2@comcast.net
EIA Sign In Sheet Template

Course Information

Course Objectives
  • 1) Discuss the physiological effects and treatment responses;
  • 2) Review the current evidence base for clinical use; and
  • 3) Evaluate and apply learnings from the PARIS trial to patient care

Accreditation

This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063